Newsbot

Beantragte Regelinsolvenzen im Oktober 2024: +22,9 % zum Vorjahresmonat

Statistisches Bundesamt: WIESBADEN (ots) - - 13,4 % mehr Unternehmensinsolvenzen im August 2024 als im August 2023 - 2,9 % weniger Verbraucherinsolvenzen im August 2024 als im August 2023 Die Zahl der beantragten Regelinsolvenzen in Deutschland ist nach vorläufigen Angaben ...

Subsea 7 S.A. Announces Third Quarter 2024 Results

Luxembourg – 21 November 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY, ISIN: LU0075646355, the Company) announced today results of Subsea7 Group (the Group, Subsea7) for the third quarter which ended 30 September 2024.

Robust growth despite continued pressure in the market

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO U.S. PERSONS OR IN OR INTO ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. Interim Report July - September 2024 THIRD QUARTER · Net sales amounted to SEK 2,131.4 (1,938.1) million, an increase of 10.0%. · Organic growth amounted to 12% · Adjusted EBITDA amounted to SEK 222.5 (178.3) million, corresponding to an adjusted EBITDA margin of 10.4% · Adjusted operation...

Cereno Scientific publishes the interim report for Q3 2024 (July 1–September 30)

The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q3 2024 (July 1–September 30). Summary of the interim report for Q3 2024 (July 1–September 30) Cereno Scientific Group · Net Sales were SEK 0 (0) · Result after financial items was SEK -22,718,087 (-11,076,974) · Earnings per share was SEK -0.08 (-0.05) before dilution and SEK -0.07 (-0.05) after dilution · The equity/assets ratio was 66.8% (95.4%) · Cash and bank balance was SEK 73,841,...

Acroud publishes interim report Q3 2024: A challenging quarter

Financial highlights during third quarter 2024 • Revenue amounted to EUR 9 240 (9 868) thousand, corresponding to a decline of -6% and an organic decline of -1.3%. • Adjusted EBITDA (before items affecting comparability) was EUR 815 (1 175) thousand decreasing by 31% year-on-year. EBITDA amounted to EUR 790 (945) thousand, decreasing by 16% year-on-year. • Profit after tax was EUR -1 040 (-1 874) thousand. Adjusted profit after tax (before items affecting comparability and currency ...

Kährs Group: Interim Report July-September 2024

Increased order intake in a weak market – continued focus on efficiency and growth Kährs order intake increased in the third quarter by SEK 43 million, which corresponds to an increase of 11 percent compared to the previous year. Kährs’ turnover, however, decreased by 15 per cent organically in the third quarter due to continued weak demand in a cautious market in primarily new construction in the Nordics and North America. Profitability has been affected by the reduced sales, and the result wa...

Q3 2024 Interim report Beyond Frames Entertainment AB (publ)

CEO Comments Positioned for Record-Breaking Growth and a Robust Recurring Revenue Stream. Year-to-date, we’ve achieved an impressive 37% increase in revenue over last year, surpassing the fullyear revenue for 2023 - putting us firmly on track for a record-breaking year. Q3 revenue saw a 12% dip due to a slowdown in consumer purchases as they waited for the October launch of Meta’s new headset, the Meta Quest 3S. Our core titles still performed solidly, driven by continued growth in our games a...

IRW-News: Osisko Development Corp.: Osisko Development erhält Genehmigungen nach dem BC-Minengesetz für das Cariboo-Goldprojekt; Prozess mit Umweltverträglichkeitsprüfung wird eingeleitet

IRW-PRESS: Osisko Development Corp.: Osisko Development erhält Genehmigungen nach dem BC-Minengesetz für das Cariboo-Goldprojekt; Prozess mit Umweltverträglichkeitsprüfung wird eingeleitetMontreal, Québec, 20. November 2024 - Osisko Development Corp....

The exercise period for warrants of series TO2 commences today

Copenhagen, Denmark, 21 November 2024 - Today is the first day for the exercise of Curasight A/S’ ("Curasight" or "the Company" - TICKER: CURAS) warrants of series TO2 (“TO2”), which were issued in connection with the Companys preferential rights issue and directed issue of units in September 2024. The exercise period will run until December 5, 2024. Holders of TO2 are entitled to subscribe for one (1) new share in Curasight for each TO2 at an exercise price of DKK 11.50 per share. If all warra...

Infineon-Aktie: Ruhe vor dem Sturm - KI und Micron als Impulsgeber

Vor dem Hintergrund der schwachen gesamtwirtschaftlichen Dynamik überlagern in der Chipbranche die Bestände an vielen Stellen noch immer die Endnachfrage. Die erhoffte Belebung lässt weiter auf sich warten – auch bei Infineon. Vorstand Jochen Hanebeck hat die Investoren daher auf einen weiter verhaltenen Geschäftsverlauf eingestellt.

What Does the Adani Case Mean for Trump-Modi Ties?

The charges Gautam Adani faces from US prosecutors in an alleged $250 million bribery scheme come at a delicate time for US-India relations ahead of President-elect Donald Trumps return to the White House. The Wilson Centers Michael Kugelman and Nirmalya Kumar of the Lee Kong Chian Business School detail how Trumps existing relationship with Prime Minister Narendra Modi may affect the case as it progresses. They join Haslinda Amin on "Insight with Haslinda Amin." (Source: Bloomberg)

New preclinical data for Cereno Scientific’s novel IP Receptor Agonist CS585 presented at the AHA Scientific Sessions 2024

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced new preclinical data indicating that drug candidate CS585, a novel prostacyclin (IP) receptor agonist, inhibits platelet activation and clot formation up to 24 hours post-administration. The new data was presented at the AHA Scientific Sessions 2024, in Chicago on November 16, 2024. “We are delighted to ...

JPMorgan belässt Novartis auf Neutral - Ziel 95 Franken

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Novartis mit einem Kursziel von 95 Franken auf "Neutral" belassen. Analyst Richard Vosser rechnet am Donnerstagmorgen mit einer positiven Kursreaktion auf die neuen Mittelfristziele. Sie ließen weiteren Spielraum für die Markterwartungen. [mehr]

Strenge Social Media-Regeln in Australien werden konkret

Es könnte eine der strengsten Regeln für die Nutzung sozialer Medien werden: Australiens Regierung brachte einen Gesetzentwurf auf den Weg, der Kindern und Jugendlichen unter 16 Jahren den Zugang verbietet. Ein Vorbild für andere Länder?

MORNING BRIEFING - Deutschland/Europa -2-

Die Ölpreise zeigten sich volatil, gaben unter dem Strich aber um 0,6 Prozent nach. Gegenwind kam von den US-Rohöllagerbeständen, die unerwartet gestiegen waren. METALLE zuletzt Vortag +/- % +/- USD % YTD Gold ...

MORNING BRIEFING - Deutschland/Europa

Der Markt-Überblick am Morgen, zusammengestellt von Dow Jones Newswires. === +++++ TAGESTHEMA +++++ Nvidia hat im dritten Geschäftsquartal von der anhaltend starken Nachfrage nach Chips für KI-Anwendungen profitiert. Der Umsatz stieg ...

Deutsche Bank Research hebt Rheinmetall auf Buy - Ziel 700 Euro

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Rheinmetall von "Hold" auf "Buy" hochgestuft und das Kursziel von 550 auf 700 Euro angehoben. Christoph Laskawi hatte das Wachstumspotenzial der Düsseldorfer laut seiner am Donnerstag vorliegenden Analyse im Vorfeld des jüngsten Kapitalmarkttags zu konservativ eingeschätzt. [mehr]

[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Apheresis Equipment Market size & share revenue was valued at approximately USD 4,165.1 Million in 2023 and is expected to reach USD 4,673.2 Million in 2024 and is expected to reach around USD 13,169.1 Million by 2033, at a CAGR of 12.2% between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are Terumo BCT Inc., F...

Fondia continues employee share savings plan (ESSP) for the 2025–2026 savings period

Fondia Plc Company release 21 November 2024 at 8.30 a.m. EET In autumn 2018, the Board of Directors of Fondia Plc (the "Company") decided to introduce an employee share savings plan (the “ESSP”) for the Groups employees. The ESSP has so far consisted of six twelve-month savings periods since 2019. The Companys Board of Directors has now decided to extend the ESSP for the 2025–2026 savings period. The ESSP is open to all Fondia Group’s employees, excluding trainees. The 2025–2026 savings p...